Richard Payerchin

Data from reports on two new West Health-Gallup polls.

ACP also calls for action on prior authorizations.

MedPAC starts deliberations on 2026 reimbursement recommendation to Congress.

Researchers asked doctors why they continue with fee-for-service payment. There are many reasons, as a study co-author explains.

As health care sector readies for change in the White House, Big Cities Health Coalition outlines policy priorities for next year.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

Rep. Greg Murphy, MD, discusses his bill to stop the planned Medicare reimbursement reduction.

Ferguson, who opposed ban of noncompetes, named to succeed Chair Khan; new commissioner Meador called for PBM regulations.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

Monthly report shows gains for hospitals, home health care services.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

The Commonwealth Fund compares United States with other developed nations.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.

‘Old guys are taking ER call’ as younger docs ponder medicine as a calling, or just a job.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

The clock is ticking for lawmakers to approve policies that could affect U.S. health care.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.